BLACK BOX WARNING
- severe liver injury and acute liver failure, some resulting in death or liver transplant; reserve PTU for patients who cannot tolerate methimazole; monitor LFTs during therapy
propylthiouracil
Brand: PTU
⚠ BBW Prototype: methimazole
Drug Class: thionamide
Drug Family: antithyroid
Subclass: antithyroid agent
Organ Systems: endocrine
Mechanism of Action
Inhibits thyroid peroxidase, blocking oxidation of iodide and coupling of iodotyrosines to form T3 and T4. Uniquely also inhibits peripheral 5'-deiodinase, reducing conversion of T4 to the more active T3 — this additional mechanism makes PTU the preferred agent in thyroid storm for rapid hormone reduction.
thyroid peroxidase (TPO)5'-deiodinase
Indications
- hyperthyroidism (Graves' disease)
- thyroid storm (drug of choice)
- pregnancy hyperthyroidism (first trimester preferred over methimazole)
Contraindications
- PTU-induced hepatotoxicity history
Adverse Effects
Common
- rash
- pruritus
- arthralgia
- nausea
- headache
Serious
- agranulocytosis (0.5%)
- hepatotoxicity (including fatal fulminant hepatic failure)
- ANCA-positive vasculitis
- lupus-like syndrome
Pharmacokinetics (ADME)
| Absorption | oral; rapidly absorbed; bioavailability ~80–90% |
| Distribution | concentrated in thyroid gland; minimal protein binding |
| Metabolism | hepatic glucuronidation; does NOT cross placenta as readily as methimazole |
| Excretion | renal |
| Half-life | 1–2 hours |
| Onset | days to weeks (thyroid stores must deplete) |
| Peak | hours |
| Duration | continuous dosing required |
| Protein Binding | ~75–80% |
| Vd | 0.4 L/kg |
Drug Interactions
| Drug / Agent | Mechanism | Severity |
|---|---|---|
| warfarin | PTU reduces vitamin K clotting factor synthesis via hyperthyroidism control; monitor INR | major |
| digoxin | as hyperthyroidism resolves, digoxin levels rise; dose adjustment may be needed | moderate |
Nursing Considerations
- Monitor CBC with differential weekly for the first 3 months; instruct patient to report fever, sore throat, or mouth sores immediately — these may indicate agranulocytosis.
- Monitor LFTs closely; serious and fatal hepatic failure has occurred; discontinue at first signs of hepatic injury (jaundice, abdominal pain, dark urine).
- PTU is preferred in the first trimester of pregnancy over methimazole (which is associated with aplasia cutis in early pregnancy).
- Administer in 3 divided doses every 8 hours; use consistently with respect to meals.
Clinical Pearls
- PTU is the drug of choice in thyroid storm because its inhibition of 5'-deiodinase prevents peripheral T4→T3 conversion, rapidly reducing thyroid hormone bioactivity — methimazole lacks this effect.
- The FDA issued a black box warning for hepatotoxicity in 2010; PTU should now be reserved for specific indications (thyroid storm, first-trimester pregnancy, methimazole allergy) rather than as a routine first-line agent.
Safety Profile
Pregnancy use-with-caution
Lactation use-with-caution
Renal Adjustment Not required
Hepatic Adjustment Required
TDM Not required
Concordance Terms
Cross-referenced clinical concepts — click any term to see all content where it appears.